Phillip Periman

991 total citations
26 papers, 693 citations indexed

About

Phillip Periman is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Phillip Periman has authored 26 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Infectious Diseases. Recurrent topics in Phillip Periman's work include Glycosylation and Glycoproteins Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Phillip Periman is often cited by papers focused on Glycosylation and Glycoproteins Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Phillip Periman collaborates with scholars based in United States, Switzerland and Tunisia. Phillip Periman's co-authors include Ivor Royston, Panpit Klug, Joel L. Moake, John Byrnes, John L. Sullivan, Elliott Perlin, Matthew D. Scharff, A. Bargellesi, Lina Asmar and Kristi A. Boehm and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Oncology.

In The Last Decade

Phillip Periman

25 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phillip Periman United States 13 293 254 180 147 131 26 693
ML Hansmann Germany 15 348 1.2× 244 1.0× 114 0.6× 151 1.0× 77 0.6× 31 895
Kazuyuki Yamaguchi Japan 15 146 0.5× 367 1.4× 165 0.9× 158 1.1× 271 2.1× 52 844
F Invernizzi Italy 14 238 0.8× 97 0.4× 303 1.7× 86 0.6× 66 0.5× 39 1.0k
James P. O'Brien United States 14 458 1.6× 165 0.6× 192 1.1× 169 1.1× 25 0.2× 37 1.2k
Ch. Marth Austria 14 235 0.8× 289 1.1× 58 0.3× 193 1.3× 277 2.1× 50 811
G. J. Ossenkoppele Netherlands 18 308 1.1× 218 0.9× 50 0.3× 164 1.1× 309 2.4× 51 832
Kristján Steinsson Iceland 13 235 0.8× 751 3.0× 143 0.8× 104 0.7× 57 0.4× 17 1.1k
Anne Bukh Denmark 16 156 0.5× 141 0.6× 130 0.7× 167 1.1× 101 0.8× 35 789
Eddie Hu United States 13 383 1.3× 336 1.3× 96 0.5× 100 0.7× 91 0.7× 23 1.1k
Avi B. Markowitz United States 16 561 1.9× 220 0.9× 383 2.1× 245 1.7× 69 0.5× 35 1.1k

Countries citing papers authored by Phillip Periman

Since Specialization
Citations

This map shows the geographic impact of Phillip Periman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Periman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Periman more than expected).

Fields of papers citing papers by Phillip Periman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Periman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Periman. The network helps show where Phillip Periman may publish in the future.

Co-authorship network of co-authors of Phillip Periman

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Periman. A scholar is included among the top collaborators of Phillip Periman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Periman. Phillip Periman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sonpavde, Guru, Phillip Periman, Douglas Weckstein, et al.. (2009). Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy. Annals of Oncology. 21(2). 319–324. 115 indexed citations
2.
Periman, Phillip, Guru Sonpavde, Douglas Weckstein, et al.. (2008). Sunitinib malate for metastatic castration resistant prostate cancer following docetaxel-based chemotherapy. Journal of Clinical Oncology. 26(15_suppl). 5157–5157. 12 indexed citations
3.
Rohrer, James E., et al.. (2006). Risk of mistaken DNR orders. Supportive Care in Cancer. 14(8). 871–873. 4 indexed citations
4.
Smalley, Stephen R., Jacqueline Benedetti, Stephen K. Williamson, et al.. (2006). Phase III Trial of Fluorouracil-Based Chemotherapy Regimens Plus Radiotherapy in Postoperative Adjuvant Rectal Cancer: GI INT 0144. Journal of Clinical Oncology. 24(22). 3542–3547. 111 indexed citations
5.
6.
Sondak, Vernon K., P. Y. Liu, Lawrence E. Flaherty, et al.. (1999). A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group study.. PubMed. 5(1). 41–7. 14 indexed citations
7.
8.
Mattes, Carol E., S. Sridhara, Phillip Periman, & K. John Morrow. (1991). Ascites produced in recalcitrant hybridomas by backcrossing to a parental myeloma. Journal of Immunological Methods. 144(2). 241–245. 2 indexed citations
9.
Byrnes, John, Joel L. Moake, Panpit Klug, & Phillip Periman. (1990). Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. American Journal of Hematology. 34(3). 169–174. 105 indexed citations
10.
Wiernik, P H, Delvyn C. Case, Phillip Periman, et al.. (1989). A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia.. PubMed. 16(1 Suppl 2). 25–9. 29 indexed citations
11.
Periman, Phillip, et al.. (1986). Vascular access for cancer chemotherapy.. PubMed. 82(10). 44–5. 2 indexed citations
12.
Periman, Phillip, et al.. (1985). Comparative evaluation of two outpatient antiemetic regimens for cancer chemotherapy.. PubMed. 81(7). 44–5. 1 indexed citations
13.
Levine, Paul H., J. H. C. Ho, Francis Nkrumah, et al.. (1978). Delayed hypersensitivity reactions of cancer patients to antigens on lymphoid cell lines. International Journal of Cancer. 22(4). 400–404. 2 indexed citations
14.
Periman, Phillip, Paul H. Levine, Dharam V. Ablashi, & Ivor Royston. (1977). Cell mediated immunity during infectious mono‐nucleosis to epstein‐barr virus associated antigens. International Journal of Cancer. 20(4). 506–511. 13 indexed citations
15.
Royston, Ivor, John L. Sullivan, Phillip Periman, & Elliott Perlin. (1975). Cell-Mediated Immunity to Epstein–Barr-Virus-Transformed Lymphoblastoid Cells in Acute Infectious Mononucleosis. New England Journal of Medicine. 293(23). 1159–1163. 95 indexed citations
16.
Periman, Phillip, et al.. (1975). Acute Arthritis Induced by Isoniazid. Annals of Internal Medicine. 83(5). 667–668. 4 indexed citations
17.
Bargellesi, A., Phillip Periman, & Matthew D. Scharff. (1972). Synthesis, Assembly, and Secretion of γ Globulin by Mouse Myeloma Cells. The Journal of Immunology. 108(1). 126–134. 22 indexed citations
18.
Periman, Phillip, et al.. (1972). Herpesvirus saimiri in marmoset-mouse hybrid cell lines.. PubMed. 49(2). 387–93. 3 indexed citations
19.
Bargellesi, A., Phillip Periman, & Matthew D. Scharff. (1972). Synthesis, assembly, and secretion of globulin by mouse myeloma cells. IV. Assembly of IgA.. PubMed. 108(1). 126–34. 33 indexed citations
20.
Periman, Phillip. (1970). IgG Synthesis in Hybrid Cells from an Antibody-producing Mouse Myeloma and an L Cell Substrain. Nature. 228(5276). 1086–1087. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by ML Hansmann Breakdown of academic impact, for papers by Kazuyuki Yamaguchi Breakdown of academic impact, for papers by F Invernizzi Breakdown of academic impact, for papers by James P. O'Brien Breakdown of academic impact, for papers by Ch. Marth Breakdown of academic impact, for papers by G. J. Ossenkoppele Breakdown of academic impact, for papers by Kristján Steinsson Breakdown of academic impact, for papers by Anne Bukh Breakdown of academic impact, for papers by Eddie Hu Breakdown of academic impact, for papers by Avi B. Markowitz
Rankless by CCL
2026